Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Infectious Diseases
Volume 2015, Article ID 340725, 3 pages
http://dx.doi.org/10.1155/2015/340725
Case Report

Recurrent Candida albicans Ventriculitis Treated with Intraventricular Liposomal Amphotericin B

Department of Pediatrics, Marmara University School of Medicine, 3500 Istanbul, Turkey

Received 28 May 2015; Revised 20 September 2015; Accepted 27 September 2015

Academic Editor: Paola Di Carlo

Copyright © 2015 Demet Toprak et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. E. Lee, P.-Y. Cheung, J. L. Robinson, C. Evanochko, and C. M. T. Robertson, “Comparative study of mortalitiy and morbidity in premature infants (birth weight<1250 gr) with candidemia or candidal meningitis,” Clinical Infectious Diseases, vol. 27, no. 3, pp. 559–565, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Sánchez-Portocarrero, P. Martín-Rabadán, C. J. Saldaña, and E. Pérez-Cecilia, “Candida cerebrospinal fluid shunt infection report of two new cases and review of the literature,” Diagnostic Microbiology & Infectious Disease, vol. 20, no. 1, pp. 33–40, 1994. View at Publisher · View at Google Scholar · View at Scopus
  3. P. G. Pappas, C. A. Kauffman, D. Andes et al., “Clinical practice guidelines for the management candidiasis: 2009 update by the Infectious Diseases Society of America,” Clinical Infectious Diseases, vol. 48, no. 5, pp. 503–535, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. W. W. Hope, E. Castagnola, A. H. Groll et al., “ESCMID guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp,” Clinical Microbiology and Infection, vol. 18, no. 7, pp. 38–52, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Udeta Mora and L. F. Sanches Perez, “Meningitis caused by Candida in premature infant,” Boletín Médico del Hospital Infantil de México, vol. 36, pp. 239–245, 1979. View at Google Scholar
  6. G. Galli, M. Gandolfini, A. Lenzi, G. Gatta, and G. Marini, “Intraventricular and intravenous use of amphotericin B in a case of non-surgical cerebral aspergillosis,” Journal of Neurosurgical Sciences, vol. 27, no. 1, pp. 59–61, 1983. View at Google Scholar
  7. J. F. Fisher and J. Dewald, “Parkinsonism associated with intraventricular amphotericin B,” Journal of Antimicrobial Chemotherap, vol. 12, no. 1, pp. 97–99, 1983. View at Publisher · View at Google Scholar
  8. S. Shapiro, T. Javed, and J. Mealey Jr., “Candida albicans shunt infection,” Pediatric Neuroscience, vol. 15, no. 3, pp. 125–130, 1989. View at Publisher · View at Google Scholar · View at Scopus
  9. A. H. Groll, N. Giri, V. Petraitis et al., “Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system,” Journal of Infectious Diseases, vol. 182, no. 1, pp. 274–282, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Sánchez-Portocarrero, E. Pérez-Cecilia, O. Corral, J. Romero-Vivas, and J. J. Picazo, “The central nervous system and infection by Candida species,” Diagnostic Microbiology and Infectious Disease, vol. 37, no. 3, pp. 169–179, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. H. S. Jafari, X. Saez-Llorens, C. Severien et al., “Effects of antifungal therapy on inflammation, sterilization, and histology in experimental Candida albicans meningitis,” Antimicrobial Agents and Chemotherapy, vol. 38, no. 1, pp. 83–89, 1994. View at Publisher · View at Google Scholar · View at Scopus
  12. R. A. Voice, S. F. Bradley, J. A. Sangeorzan, and C. A. Kauffman, “Chronic candidal meningitis: an uncommon manifestation of candidiasis,” Clinical Infectious Diseases, vol. 19, no. 1, pp. 60–66, 1994. View at Publisher · View at Google Scholar · View at Scopus
  13. H. A. Torres, R. Y. Hachem, R. F. Chemaly, D. P. Kontoyiannis, and I. I. Raad, “Posaconazole: a broad-spectrum triazole antifungal,” The Lancet Infectious Diseases, vol. 5, no. 12, pp. 775–785, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. S. C. Deresinski and D. A. Stevens, “Caspofungin,” Clinical Infectious Diseases, vol. 36, no. 11, pp. 1445–1457, 2003. View at Publisher · View at Google Scholar · View at Scopus